ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 599 out of 6645

$833K Total Retail Price of All Prescriptions

Rank: 460 out of 6645

330 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 330 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

45% of this provider’s 330 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,117 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 463 371 1 1
PANTOPRAZOLE SODIUM 454 399 2 29
METFORMIN HCL 428 355 3 7
GLIPIZIDE 408 313 4 23
HYDROCODONE-ACETAMINOPHEN 383 206 S3 5 5
LISINOPRIL 327 262 6 3
OMEPRAZOLE 292 203 7 6
BENAZEPRIL HCL 291 242 8 21
AMLODIPINE BESYLATE 262 232 9 2
SERTRALINE HCL 235 184 10 43
ACETAMINOPHEN-CODEINE 221 194 S3 11 80
GABAPENTIN 217 173 12 18
JANUVIA 212 176 13 38
LEVOTHYROXINE SODIUM 187 142 14 4
DIOVAN 182 148 15 19
PRAVASTATIN SODIUM 173 165 16 20
FUROSEMIDE 166 123 17 11
ESCITALOPRAM OXALATE 165 127 18 86
CITALOPRAM HBR 163 128 19 35
ZOLPIDEM TARTRATE 154 129 20 17
ENALAPRIL MALEATE 144 121 21 75
ATELVIA 143 131 22 91
HYDROCHLOROTHIAZIDE 139 86 23 9
ATORVASTATIN CALCIUM 138 105 24 10
ACTOS 131 99 25 71
LOSARTAN POTASSIUM 124 105 26 12
CRESTOR 123 108 27 34
METOPROLOL SUCCINATE 115 85 28 24
TRAZODONE HCL 111 77 29 60
LEVOFLOXACIN 105 81 30 83
TAMSULOSIN HCL 96 88 31 22
BYSTOLIC 95 95 32 110
AZOR 85 52 33 152
SPIRIVA 84 70 34 65
ACIPHEX 82 58 35 167
IBUPROFEN 81 58 36 42
ATENOLOL 80 57 37 8
VIIBRYD 79 63 38 555
BENICAR 78 68 39 84
METOPROLOL TARTRATE 77 59 40 13
CLONIDINE HCL 75 47 41 56
NAMENDA 71 71 42 41
POTASSIUM CHLORIDE 68 63 43 28
WARFARIN SODIUM 66 33 44 16
CARVEDILOL 65 51 45 25
CLOPIDOGREL 64 47 46 36
FENOFIBRATE 64 36 46 74
PIOGLITAZONE HCL 63 45 R 48 184
CELEBREX 63 61 48 54
ALLOPURINOL 61 55 50 31
LOVASTATIN 60 51 51 15
AVODART 59 42 52 99
VENLAFAXINE HCL ER 58 38 53 175
DONEPEZIL HCL 54 54 54 27
DOXAZOSIN MESYLATE 54 43 54 81
SAVELLA 53 25 56 570
SINGULAIR 52 38 57 76
RANITIDINE HCL 52 29 57 51
MELOXICAM 51 36 59 46
JANUMET 50 37 60 132
AZITHROMYCIN 50 33 60 44
HYDRALAZINE HCL 50 25 60 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.